1. Home
  2. PESI vs CRBP Comparison

PESI vs CRBP Comparison

Compare PESI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$9.81

Market Cap

208.1M

Sector

Industrials

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$7.75

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
CRBP
Founded
1990
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
184.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
PESI
CRBP
Price
$9.81
$7.75
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
282.6K
619.9K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
$4,822,272.00
Revenue This Year
$34.62
N/A
Revenue Next Year
$77.02
$116.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$8.14
$6.73
52 Week High
$16.50
$20.56

Technical Indicators

Market Signals
Indicator
PESI
CRBP
Relative Strength Index (RSI) 44.25 36.77
Support Level $9.82 $7.72
Resistance Level $12.33 $8.87
Average True Range (ATR) 0.68 0.98
MACD 0.09 -0.41
Stochastic Oscillator 54.12 5.00

Price Performance

Historical Comparison
PESI
CRBP

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: